Roquefort Therapeutics PLC (ROQ)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1.20p
Buy
1.40p
0.00p (+0.00%)
Prices updated at 19 Dec 2025, 11:00 GMT
| Prices minimum 15 mins delay
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 200,000 | - | |
| 200,000 | -16,000 | |
| -2m | -1m | |
| -966.82 | - | |
| -2m | -971,803 | |
| -2m | -1m | |
| Sales, General and administrative | 642,860 | 541,289 |
| Interest expenses | 58 | 44,857 |
| Provision for income taxes | -187,693 | -242,766 |
| Operating expenses | 2m | 1m |
| Income before taxes | -2m | -1m |
| Net income available to common shareholders | -2m | -971,803 |
| -0.0135 | -0.0075 | |
| Net interest income | 1,411 | -97,650 |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.0135 | -0.0075 |
| Free cash flow per share | -0.0269 | -0.0103 |
| Book value/share | 0.0501 | 0.0363 |
| Debt equity ratio | - | - |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 694,911 | 362,492 |
| Current liabilities | 307,114 | 579,815 |
| Total capital | 5m | 5m |
| Total debt | - | 400,092 |
| Total equity | 5m | 5m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 6m | 6m |
| Total liabilities | - | - |
| Cash and cash equivalents | 537,322 | 337,112 |
| Common stock | 129m | 136m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 2m | 537,322 |
| Cash dividends paid | - | - |
| -2m | -783,731 | |
| Investments (gains) losses | -52,573 | - |
| 537,322 | 337,112 | |
| Net income | - | - |
| -2m | -783,731 | |
| -54,042 | - |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
